Moreover, in most cancers except GBM, LGG, CHOL, UCEC, HNSC, lung squamous cell carcinoma (LUSC), and OV, there was a moderate positive correlation between ADA1 and immune checkpoints. This evidence concerns the gene ADA and cancer.